KBC

Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.

Fnality International provides a digital cash system that uses blockchain technology to settle financial transactions. It was established in April 2019 and is headquartered in London, England. Fnality is the commercial realisation of a four-year Research & Development project called the "Utility Settlement Coin," which was first proposed by UBS and London-based blockchain company Clearmatics.

Hipobroker is a provider of financial services in Serbia & Montenegro and offers information useful for security portfolios.

Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.

Together with thousands of other merchants, you are the beating heart of your neighbourhood. From that hot cup of coffee while your customer waits, to that little extra for that loyal customer having a tough day. Every single day, you go that extra mile for your customers. We combined all of your extra efforts into one single app. With Joyn, your customers enjoy unique advantages, save for cool rewards and keep coming back to you. Joyn provides you the tools to help you grow your business.

The revolution in learning, the skills of tomorrow trained today. At Stellar Labs we have found a way to solve the skills gap in the tech sector. A science based way, backed by research to achieve the best performance and return on investment. Learners are energised and engaged to quickly master high-demand technical skills and capabilities. We focus on results-driven solutions to help the technical workforce thrive today and lead the change into tomorrow. The technology market is booming, but the industry faces a global talent shortage. Stellar Labs provides the answer – and the competitive advantage.

Banco Urquijo specializes in advising and managing legal entities, such as insurance companies, mutual companies, provident societies, cooperatives, and trusts that administer third party assets.

Aballea Finance SA is a privately held company operates as a wealth management and real estate management company.

Almanij NV engages in banking, insurance, and investment activities; and the provision of specialized financial services.

Wizata is make sense of your data and discover unique solutions and unexploited opportunities. Wizata proposes vertical solutions answering to your specific sector challenges. As main domains of expertize, Wizata counts today the Manufacturing (Industry 4.0), Insurance, Energy, Healthcare sectors and e-commerce for predictive management and process optimization. By embedding themselves in your business and synergising with your teams, WIZATA’s data scientists uncover hidden gems within your data, whether internal or external to your organisation. Every profile is an exception, that’s why WIZATA offers an advanced collaboration model with people who are real experts in data science. Unique profiles for unique services.

Movetis NV, a pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company's lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women. Resolor is also tested for chronic constipation in males and children, as well as opioid-induced constipation and post operative ileus. Its products also include M0002, which is in Phase II trials to treat ascites, an accumulation of fluid caused by liver malfunction; and M0003 that is entering Phase II development for symptomatic treatment of heartburn and regurgitation in patient's refractory to PPIs, and pediatric reflux. In addition, the company also has two prioritized compounds out of its preclinical portfolio, M0014 and M0012, and two compound libraries. It has partnership agreements with the universities of Ghent, Leuven, and Rotterdam. The company was founded in 2006 and is headquartered in Turnhout, Belgium.

K&H bank provide comprehensive financial services and solutions to our clients, and give them advice in making smart decisions.

Senzal is a privately held brokerage service company.

Aristo Music NV develops selection and distribution techniques and technologies for digital music and provides music related services. The company also develops various Internet applications, which include a Web radio that consists of a musical database. It serves catering, retail, business, leisure, and government markets. The company is based in Heverlee, Belgium.

To this end, arGEN-X has invented and developed a breakthrough discovery platform setting the new standard for antibody lead choice in the discovery of human antibody therapeutics. Fuelled by the best possible natural immune responses available, our Simple Antibodyâ„¢ platform leapfrogs existing platforms in what is probably the most critical aspect of drug discovery and development: lead choice.

DZI is an Insurance company in Bulgaria, offering a wide range of Life and Non-life Insurance products, as well as bankassurance.

The revolution in learning, the skills of tomorrow trained today. At Stellar Labs we have found a way to solve the skills gap in the tech sector. A science based way, backed by research to achieve the best performance and return on investment. Learners are energised and engaged to quickly master high-demand technical skills and capabilities. We focus on results-driven solutions to help the technical workforce thrive today and lead the change into tomorrow. The technology market is booming, but the industry faces a global talent shortage. Stellar Labs provides the answer – and the competitive advantage.

WARTA S.A. was established in 1920. Since then it's been setting standards on the Polish insurance market. The Company is one of the largest and oldest insurance companies in Poland.

Swiss Capital S.A. is an investment brokerage services in Romania. The company serves institutional clients and high net worth individuals.

CitizenLab (https://www.citizenlab.co) is a civic engagement platform on which citizens co-create their city. The platform facilitates a two-way communication between the city and its citizens. Citizens post ideas, interact on them and upvote the best ideas. On the other hand, the city uses CitizenLab to consult the opinion of its citizens via polling or to ask their creative solutions to an existing problem. Our SaaS solution is the medium for cities to make decision-making more democratic, more transparent and more collaborative through citizensourcing.

Effectenbank Stroeve N.V. is a privately held company offers capital management, stockbroking, and investment advisory services.

Ceres is a non-profit organization that advocates for sustainability leadership. The organization mobilizes a network of investors, companies, and public interest groups to accelerate and expand the adoption of sustainable business practices and solutions to build a healthy economy. It also carries out research in business sustainability trends as well as insurance and banking sector responses to climate change, electric utilities emissions, fuel economy standards, and climate risk disclosure. Ceres is headquartered in Boston, Massachusetts.

NN Group-Pension and life insurance businesses offer Life Insurance, Mandatory Pensions, and Voluntary Pensions.

Istrobanka is a provider of retail and wholesale banking products and services for corporate and individual customers in Slovakia. The company offers deposit products, savings and investment accounts, loans, corporate finance, insurance products, payment cards, mutual funds, and mortgage loans.

Richelieu Finance is an investment management company.

Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

KBC Equitas is a privately held company operates a stock exchange and offers online brokerage services.

Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases. The strategic acquisition of Okapi further enhances Aratana's leadership position in pet therapeutics by bringing with it a unique combination of individuals, strong relationships with academic institutions, novel technologies and products, and favorable geographic location. Aratana plans to continue to advance the current Okapi pipeline of high value antiviral drugs, including its feline herpes and feline immunodeficiency virus franchises.

Banca KBL Fumagalli Soldan S.p.A. offers corporate, retail and private and investment banking services. It provides financial services worldwide.

Aurel Leven Gestion, an independent asset management company, old, which manages funds on behalf of private clients and institutional investors. Aurel Leven Gestion, of February 2005, Aurel Leven Gestion was acquired by KBL France Gestion.

BIC specialises in assisting international investors in acquiring businesses, as well as local companies in attracting strategic partners, and can look back on a number of successfully completed M&A transactions. From one region to another, the value of the deals it works on varies between 10 and 200 million euros. Its business portfolio is spread evenly across the various regions in which the company operates. BIC targets midcaps and is a strong player in the financial services, consumer goods, retail, distribution and selected industrial sectors.

Absolut Bank was established in 1993. The bank has about 200 thousand clients all over Russia. The bank has more than 30 thousand corporate clients from different economic sectors such as consumer goods, metals, machine-building, automobile, oil, energy, food and processing industries, telecommunications and information technologies, construction, commerce, transportation, pharmaceutical industry and medical equipment production, publishing and printing, chemical industry, agribusiness and other branches. Absolut Bank offers all of its corporate clients a full spectrum of financial services, including all types of financing, a package of cash and settlement services, additional investment and other opportunities. One of the strategic priorities for Absolut Bank is development of services in the segment of individual clients. In every area of its business, the bank offers new terms, some of them being the most attractive in the market, and excellent service.

CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.

To this end, arGEN-X has invented and developed a breakthrough discovery platform setting the new standard for antibody lead choice in the discovery of human antibody therapeutics. Fuelled by the best possible natural immune responses available, our Simple Antibodyâ„¢ platform leapfrogs existing platforms in what is probably the most critical aspect of drug discovery and development: lead choice.

HSBC Dewaay SA is a privately held company offers private banking and trustee services. It services include cash management, discretionary portfolio management, and patrimonial advisory services.

VB LEASING SK, spol. s r.o., a leasing company, focuses on financing movable objects. It finances personal and utility vehicles, machines, equipment and technologies, and computing technology solutions. It also offers financing through credit. The company serves corporate and private clients in Slovakia. VB LEASING SK, spol. s r.o. was formerly known as LB-Leasing spol. s r.o. and changed its name to VB LEASING SK, spol. s r.o. in 2002. The company was founded in 1994 and is headquartered in Bratislava, Slovakia. As of July 21, 2015, VB LEASING SK, spol. s r.o. operates as a subsidiary of CSOB Leasing, a.s..

CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.

Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

ArtiQ NV develops ArtiQ|PFT, an artificial intelligence-based medical software that helps doctors to diagnose, treat, and monitor respiratory problems. Its software automatically processes pulmonary function test data and generates a clinical report. ArtiQ NV was founded in 2019 and is based in Leuven, Belgium.

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.

UBB Interlease is a Bulgarian lease company part of the Belgian banking and insurance group KBC. The activities of Interlease are targeted towards increasing the competitiveness and improving the market positions of the Bulgarian enterprises both domestically and abroad. Interlease finances the acquisition of high-quality equipment, transportation vehicles, cars and office equipment. The company provides its customers with professional service after delivery of the asset, based on effective internet and mobile technologies.

Romstal Leasing is the largest independent leasing company in Romania. At the end of 2006, it held a 4.20% share of the Romanian leasing market and was ranked thirteenth. The bulk of its financing activity (43.30%) relates to car leasing, but it also leases delivery vans, lorries, machinery and equipment and real estate.

United Bulgarian Bank provides various banking products and services to individual, microbusiness, and corporate clients in Bulgaria. Its deposit products include savings accounts, current accounts, online deposits and accounts, and cash management accounts. The company also offers various loan products, including consumer loans, mortgage loans, overdrafts, revolving credit lines, working capital loans, investment loans, credit lines, agriculture loans, loans under European programs, guarantee programs, and credit programs, as well as debit and credit cards.